WITH compliance levels for chronic-disease-states medicines as low as 50%, recent research in the UK has confirmed that counselling has a strong role in enhancing patient adherence to statin therapy.
The new study showed there were five main barriers to the use of statins: scepticism about clinician's motivations; side effects and possible toxicity; cost; unclear benefits, and fear of dependence.
Two themes drove statin usage: believing statins work as a positive step to prolonging good quality of life and convenience in fitting them into the daily routine.
University of Exeter Medical School authors of the meta-analysis involving 888 participants across eight countries, said, "Frank conversations about the benefits and risks for each individual with discussion addressing the patient's specific concerns, priorities and goals are an important step in facilitating statin use and adherence" - CLICK HERE to access.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Oct 18
